JP2022518288A5 - - Google Patents
Info
- Publication number
- JP2022518288A5 JP2022518288A5 JP2021543276A JP2021543276A JP2022518288A5 JP 2022518288 A5 JP2022518288 A5 JP 2022518288A5 JP 2021543276 A JP2021543276 A JP 2021543276A JP 2021543276 A JP2021543276 A JP 2021543276A JP 2022518288 A5 JP2022518288 A5 JP 2022518288A5
- Authority
- JP
- Japan
- Prior art keywords
- polymorph
- composition
- pharmaceutical composition
- approximately
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024226332A JP2025036479A (ja) | 2019-01-23 | 2024-12-23 | 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19153315.7 | 2019-01-23 | ||
| EP19153315 | 2019-01-23 | ||
| PCT/EP2020/051528 WO2020152226A1 (en) | 2019-01-23 | 2020-01-22 | Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024226332A Division JP2025036479A (ja) | 2019-01-23 | 2024-12-23 | 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022518288A JP2022518288A (ja) | 2022-03-14 |
| JP2022518288A5 true JP2022518288A5 (enExample) | 2023-01-20 |
| JP7611148B2 JP7611148B2 (ja) | 2025-01-09 |
Family
ID=65228356
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543276A Active JP7611148B2 (ja) | 2019-01-23 | 2020-01-22 | 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物 |
| JP2024226332A Pending JP2025036479A (ja) | 2019-01-23 | 2024-12-23 | 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024226332A Pending JP2025036479A (ja) | 2019-01-23 | 2024-12-23 | 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11891350B2 (enExample) |
| EP (1) | EP3860582B1 (enExample) |
| JP (2) | JP7611148B2 (enExample) |
| KR (1) | KR20210119403A (enExample) |
| CN (1) | CN113329746B (enExample) |
| AU (1) | AU2020210831B2 (enExample) |
| BR (1) | BR112021019476A2 (enExample) |
| CA (1) | CA3118996A1 (enExample) |
| DK (1) | DK3860582T3 (enExample) |
| ES (1) | ES2913977T3 (enExample) |
| IL (1) | IL282718B2 (enExample) |
| PL (1) | PL3860582T3 (enExample) |
| PT (1) | PT3860582T (enExample) |
| RS (1) | RS63270B1 (enExample) |
| SG (1) | SG11202111773QA (enExample) |
| WO (1) | WO2020152226A1 (enExample) |
| ZA (1) | ZA202107346B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3939578A1 (en) * | 2020-07-13 | 2022-01-19 | Novaremed Ltd. | Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease |
| WO2026037478A1 (en) | 2023-08-11 | 2026-02-19 | Novaremed AG | (s,s)-(3-o-(propan-2-ol)-2-amino-prop-1-yl-4-hydroxybenzene and its analogues for the treatment of chronic pain |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7642290B2 (en) | 2002-10-03 | 2010-01-05 | Novaremed Limited | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| US7674829B2 (en) | 2004-03-26 | 2010-03-09 | Novaremed Limited | Compounds for the treatment of AIDS and other viral diseases |
| GB0804213D0 (en) | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
| WO2011030205A1 (en) | 2009-09-09 | 2011-03-17 | Novaremed Ltd. | N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation |
| US8802734B2 (en) | 2009-09-09 | 2014-08-12 | Novaremed Limited | Method of treating or preventing pain |
| GB0916073D0 (en) | 2009-09-14 | 2009-10-28 | Cintec Int Ltd | Improvements in and relating to building anchor systems |
| CN103998420B (zh) * | 2011-12-08 | 2018-04-17 | 诺瓦麦有限公司 | (s)2‑n(3‑o‑(丙‑2‑醇)‑1‑丙基‑4‑羟基苯)‑3‑苯基丙酰胺的分离的立体异构形式 |
-
2020
- 2020-01-22 RS RS20220510A patent/RS63270B1/sr unknown
- 2020-01-22 KR KR1020217023524A patent/KR20210119403A/ko not_active Ceased
- 2020-01-22 BR BR112021019476A patent/BR112021019476A2/pt unknown
- 2020-01-22 PT PT207031527T patent/PT3860582T/pt unknown
- 2020-01-22 SG SG11202111773QA patent/SG11202111773QA/en unknown
- 2020-01-22 US US17/295,788 patent/US11891350B2/en active Active
- 2020-01-22 AU AU2020210831A patent/AU2020210831B2/en active Active
- 2020-01-22 CA CA3118996A patent/CA3118996A1/en active Pending
- 2020-01-22 DK DK20703152.7T patent/DK3860582T3/da active
- 2020-01-22 JP JP2021543276A patent/JP7611148B2/ja active Active
- 2020-01-22 ES ES20703152T patent/ES2913977T3/es active Active
- 2020-01-22 EP EP20703152.7A patent/EP3860582B1/en active Active
- 2020-01-22 CN CN202080010393.8A patent/CN113329746B/zh active Active
- 2020-01-22 IL IL282718A patent/IL282718B2/en unknown
- 2020-01-22 PL PL20703152.7T patent/PL3860582T3/pl unknown
- 2020-01-22 WO PCT/EP2020/051528 patent/WO2020152226A1/en not_active Ceased
-
2021
- 2021-09-23 ZA ZA2021/07346A patent/ZA202107346B/en unknown
-
2024
- 2024-12-23 JP JP2024226332A patent/JP2025036479A/ja active Pending